BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22168782)

  • 1. Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients.
    Vasileiadis I; Karakostas E; Charitoudis G; Stavrianaki A; Kapetanakis S; Kouraklis G; Karatzas T
    Eur J Clin Invest; 2012 Jun; 42(6):657-64. PubMed ID: 22168782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy.
    Karatzas T; Vasileiadis I; Charitoudis G; Karakostas E; Tseleni-Balafouta S; Kouraklis G
    Hormones (Athens); 2013; 12(4):529-36. PubMed ID: 24457401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
    Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
    Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
    Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
    Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
    Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.
    Lombardi CP; Bellantone R; De Crea C; Paladino NC; Fadda G; Salvatori M; Raffaelli M
    World J Surg; 2010 Jun; 34(6):1214-21. PubMed ID: 20052467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases.
    Medas F; Canu GL; Cappellacci F; Boi F; Lai ML; Erdas E; Calò PG
    Front Endocrinol (Lausanne); 2020; 11():551. PubMed ID: 32982963
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
    PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated?
    Dobrinja C; Pastoricchio M; Troian M; Da Canal F; Bernardi S; Fabris B; de Manzini N
    Int J Surg; 2017 May; 41 Suppl 1():S34-S39. PubMed ID: 28506411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
    Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
    World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonographic features of papillary thyroid microcarcinoma predicting high-volume central neck lymph node metastasis.
    Huang XP; Ye TT; Zhang L; Liu RF; Lai XJ; Wang L; Yang M; Zhang B; Li XY; Liu ZW; Xia Y; Jiang YX
    Surg Oncol; 2018 Jun; 27(2):172-176. PubMed ID: 29937168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound.
    Zhao C; Jiang W; Gao Y; Niu W; Zhang X; Xin L
    J Int Med Res; 2017 Jun; 45(3):1221-1230. PubMed ID: 28534700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.
    Zhou YL; Gao EL; Zhang W; Yang H; Guo GL; Zhang XH; Wang OC
    World J Surg Oncol; 2012 May; 10():67. PubMed ID: 22540396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases.
    Huang Y; Yin Y; Zhou W
    Front Endocrinol (Lausanne); 2021; 12():640565. PubMed ID: 33746905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of clinicopathologic factors on subclinical central lymph node metastasis in papillary thyroid microcarcinoma.
    Kim BY; Jung CH; Kim JW; Lee SW; Kim CH; Kang SK; Mok JO
    Yonsei Med J; 2012 Sep; 53(5):924-30. PubMed ID: 22869474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
    Xu Y; Xu L; Wang J
    J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
    Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
    J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
    Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
    Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
    Kim WY; Kim HY; Son GS; Bae JW; Lee JB
    J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
    Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
    Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.